当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析 - 现金流量表

荣昌生物

(688331)

  

流通市值:383.87亿  总市值:608.85亿
流通股本:3.56亿   总股本:5.64亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,740,879,989.09765,811,447.082,690,967,408.682,229,797,482.86
  收到的税费返还--3,199.683,199.68
  收到其他与经营活动有关的现金-4,796,924.8628,270,779.0126,135,188.33
  经营活动现金流入的其他项目68,077,870.94---
  经营活动现金流入小计5,808,957,860.03770,608,371.942,719,241,387.372,255,935,870.87
  购买商品、接受劳务支付的现金150,760,254.2787,523,962.53146,918,855.02104,074,192.63
  支付给职工以及为职工支付的现金560,914,437.47298,012,968.51,022,486,815.72776,054,088.56
  支付的各项税费126,952,744.3475,182,346.37153,666,642.53106,451,519.86
  支付其他与经营活动有关的现金756,507,485.47298,571,090.591,343,217,178.721,052,298,635.88
  经营活动现金流出小计1,595,134,921.55759,290,367.992,666,289,491.992,038,878,436.93
  经营活动产生的现金流量净额4,213,822,938.4811,318,003.9552,951,895.38217,057,433.94
二、投资活动产生的现金流量:
  收回投资收到的现金1,854,465,518.52661,881,458.682,150,000,0001,050,000,000
  取得投资收益收到的现金4,738,112.532,667,417.43,250,378.421,606,295.09
  处置固定资产、无形资产和其他长期资产收回的现金净额304,5004,5002,130,338.941,610,219.63
  收到的其他与投资活动有关的现金--9,578,4009,578,400
  投资活动现金流入小计1,859,508,131.05664,553,376.082,164,959,117.361,062,794,914.72
  购建固定资产、无形资产和其他长期资产支付的现金73,829,185.2945,064,075.73200,006,319.47175,212,674.86
  投资支付的现金3,811,191,172.03598,909,456.462,170,600,694.881,167,127,956.2
  投资活动现金流出小计3,885,020,357.32643,973,532.192,370,607,014.351,342,340,631.06
  投资活动产生的现金流量净额-2,025,512,226.2720,579,843.89-205,647,896.99-279,545,716.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金66,065,343.3727,728,930.75814,998,805.09783,623,475.65
  取得借款收到的现金273,036,887163,461,387.962,034,726,064.981,333,647,815.42
  收到其他与筹资活动有关的现金19,990,000---
  筹资活动现金流入小计359,092,230.37191,190,318.712,849,724,870.072,117,271,291.07
  偿还债务支付的现金2,064,027,920.94209,548,736.822,118,124,875.631,630,099,036.42
  分配股利、利润或偿付利息支付的现金16,871,037.5612,927,033.4971,997,261.2566,397,042.91
  支付其他与筹资活动有关的现金80,453,869.4751,247,132.18107,644,447.9849,806,464.41
  筹资活动现金流出小计2,161,352,827.97273,722,902.492,297,766,584.861,746,302,543.74
  筹资活动产生的现金流量净额-1,802,260,597.6-82,532,583.78551,958,285.21370,968,747.33
四、汇率变动对现金及现金等价物的影响-11,754,022.02-5,332,945.61-4,193,799.09-620,373.83
五、现金及现金等价物净增加额374,296,092.59-55,967,681.55395,068,484.51307,860,091.1
  加:期初现金及现金等价物余额1,154,598,527.931,154,598,527.93759,530,043.42759,530,043.42
  期末现金及现金等价物余额1,528,894,620.521,098,630,846.381,154,598,527.931,067,390,134.52
补充资料:
  净利润4,662,283,356.3-709,649,797.14-
  资产减值准备166,515.9-1,953,331.57-
  固定资产和投资性房地产折旧120,682,531.85-249,580,354.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧120,682,531.85-249,580,354.82-
  无形资产摊销4,875,523.92-9,456,147.6-
  长期待摊费用摊销323,353.19-3,871,556.75-
  待摊费用的减少160,814.08-50,901.05-
  处置固定资产、无形资产和其他长期资产的损失1,256,283.56-771,569.73-
  固定资产报废损失136,724.33-139,048.99-
  公允价值变动损失-319,862,905.01--640,713,336.7-
  财务费用29,397,156.1-74,361,912.85-
  投资损失-5,956,826.51--4,235,581.12-
  存货的减少-97,803,646.55--720,374.08-
  经营性应收项目的减少-125,162,238.67--1,023,109,780.18-
  经营性应付项目的增加-142,276,173.53-579,989,654.23-
  现金的期末余额1,528,894,620.52-1,154,598,527.93-
  减:现金的期初余额1,154,598,527.93-759,530,043.42-
  现金及现金等价物的净增加额374,296,092.59-395,068,484.51-
公告日期2026-08-252026-04-292026-03-282025-10-31
审计意见(境内)标准无保留意见
TOP↑